Follow up Study 5-6 Years After ILIT With 2 Concomitant Allergens, Birch and Grass

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2018
52 patients that had previously participated in the RDBPC study of intralymphatic immunotherapy (ILIT) with 2 concomitant allergens, birch and grass, with NCT02423707, were eligible for an open follow up 5-6 years after treatment.
Epistemonikos ID: ecade055c85b4c226ad8f0cc46d4b1eda7ff0716
First added on: May 07, 2024